Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Option exercise Director acquired 16,862 shares (option exercise)
  2. 4 Grant or award Director acquired 26,608 shares (grant or award)
  3. 4 Open-market buy Director bought 896,522 shares at an average $25.33 ($22,707,098)
  4. 4 Open-market sale Principal Accounting Officer sold 5,947 shares at $22.50 ($133,808)
  5. 4 Open-market sale EVP, Chief Financial Officer sold 15,310 shares at $22.50 ($344,475)
  6. 4 Open-market sale EVP, COO, Head of Commercial sold 14,869 shares at $22.50 ($334,553)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale EVP,General Counsel, Secretary sold 917 shares at $21.18 ($19,422)
  13. 4 Open-market sale EVP, COO, Head of Commercial sold 548 shares at $21.18 ($11,607)
  14. 4 Open-market sale CEO sold 7,806 shares at $21.18 ($165,331)
  15. 4 Open-market sale Principal Accounting Officer sold 523 shares at $18.14 ($9,487)
  16. 4 Open-market sale EVP, COO, Head of Commercial sold 1,751 shares at $18.16 ($31,798)
  17. 4 Open-market sale Principal Accounting Officer sold 701 shares at $18.16 ($12,730)
  18. 4 Open-market sale EVP, Chief Financial Officer sold 1,916 shares at $18.16 ($34,795)
  19. 4 Open-market sale CEO sold 8,582 shares at $18.16 ($155,849)
  20. 4 Open-market sale EVP,General Counsel, Secretary sold 1,456 shares at $18.16 ($26,441)

Page 7 of 35 · 686 filings